Crossmark

Celecoxib potentiates ribociclib-induced apoptosis and anti-tumor activity by co-targeting COX-2/NF-κB and PI3K/AKT/mTOR pathways in hormone receptor-positive/HER2-negative breast cancer

Crossref DOI link: https://doi.org/10.1007/s10495-026-02340-z

Published Online: 2026-04-29

Published Print: 2026-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Sanghee

Kim, Hail

Choi, Minji

Kim, Bo-Hyung

Chae, Sumin

Lee, Seok-Geun https://orcid.org/0000-0002-0060-5777
Funding

Funding for this research was provided by:

Kyung Hee University (KHU-20242590)

National Research Foundation of Korea (2022R1F1A1063638)

National Research Foundation of Korea (NRF-2021R1I1A2054560)
License Information

Text and Data Mining valid from 2026-04-29

Version of Record valid from 2026-04-29
More Information

Article History

Received: 2 September 2025

Accepted: 13 April 2026

First Online: 29 April 2026

Declarations

:

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below